ProMIS Neurosciences (PMN) Institutional Ownership → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free PMN Stock Alerts $1.84 -0.16 (-7.98%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for ProMIS Neurosciences (NASDAQ:PMN)CurrentInstitutional OwnershipPercentage50.13%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$526.68KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$9.65K Get PMN Insider Trade Alerts Want to know when executives and insiders are buying or selling ProMIS Neurosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad InvestorPlaceBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… ProMIS Neurosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/7/2024 Ieq Capital LLC30,799$35K0.0%-21.4%0.163% 11/15/2023 Affinity Asset Advisors LLC265,958$527K0.1%N/A3.100% 11/15/2022 Northeast Financial Consultants Inc100,000$613K0.0%N/A1.166% 11/4/2022 Ieq Capital LLC39,191$240K0.0%N/A0.457% (Data available from 1/1/2016 forward) PMN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PMN shares? During the previous two years, the following institutional investors and hedge funds held shares of ProMIS Neurosciences shares: Northeast Financial Consultants Inc ($613K), and Affinity Asset Advisors LLC ($527K), Ieq Capital LLC ($35K).Learn more on PMN's institutional investors. What percentage of ProMIS Neurosciences stock is owned by institutional investors? 50.13% of ProMIS Neurosciences stock is owned by institutional investors. Learn more on PMN's institutional investor holdings. Which institutional investors have been buying ProMIS Neurosciences stock? The following institutional investors have purchased ProMIS Neurosciences stock in the last 24 months: Affinity Asset Advisors LLC ($265.96K), Northeast Financial Consultants Inc ($100K), and Ieq Capital LLC ($39.19K). How much institutional buying is happening at ProMIS Neurosciences? Institutional investors have bought a total of 405,149 shares in the last 24 months. This purchase volume represents approximately $1.38M in transactions. Which ProMIS Neurosciences major shareholders have been selling company stock? The following institutional investors have sold ProMIS Neurosciences stock in the last 24 months: Ieq Capital LLC ($8.39K). How much institutional selling is happening at ProMIS Neurosciences? Institutional investors have sold a total of 8,392 shares in the last 24 months. This volume of shares sold represents approximately $9.65K in transactions. Related Companies: Marker Therapeutics Major Shareholders Sensei Biotherapeutics Major Shareholders Cara Therapeutics Major Shareholders Lexaria Bioscience Major Shareholders Xilio Therapeutics Major Shareholders Spruce Biosciences Major Shareholders Fortress Biotech Major Shareholders BriaCell Therapeutics Major Shareholders NRx Pharmaceuticals Major Shareholders Unicycive Therapeutics Major Shareholders This page (NASDAQ:PMN) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceWhat’s Really Next for America…Porter & Company[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProMIS Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.